Bluebird Bio - 1 Year Dividend History | BLUE

Historical dividend payout and yield for Bluebird Bio (BLUE) since 2023. The current TTM dividend payout for Bluebird Bio (BLUE) as of July 19, 2024 is $0.00. The current dividend yield for Bluebird Bio as of July 19, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.115B $0.004B
bluebird bio, Inc. is a clinical-stage biotechnology that is focused on developing gene therapies for severe genetic diseases and cancer. The company has developed a deep pipeline using lentiviral-based gene therapies, T-cell immunotherapy expertise, and gene editing capabilities to treat severe genetic diseases as well as cancer.?The pipeline for severe genetic diseases includes betibeglogene autotemcel (beti-cel) for the treatment of transfusion-dependent ?-thalassemia (TDT).
Stock Name Country Market Cap PE Ratio